Blue Horseshoe Stocks: EKSO New Highs & More

Ekso Bionics Holdings, Inc. EKSO

What started as a nominal gainer that came off of our extended watchlist on Wednesday, EKSO rolled its 37% performance over into yesterday’s session, carrying on the multiday action. After a  strong close at 1.81 on Thursday, we said we’d be interested in continuing to track EKSO as we head into week’s end, and it was a great idea.

The stock continued its ascent to a new high  and reached 2.18. From Wednesday’s low of 1.40, it works out to a respectable two day swing of 56% Just as we mentioned yesterday, the stock closed strong again, and we’ll want to keep monitoring for higher highs and higher lows .


Valeant Pharmaceuticals, Inc. VRX – Options Idea

Valeant has been working its way down to an area of relative support recently, consolidating after a nice run off of its 52-week lows from April to May. This morning in the premarket, we’ve taken notice of the fact that VRX is gapping up considerably in the premarket.

We want to be waiting in the wings with an options idea to take advantage of the action following what could very well be an early dip-and-rip formation. We’ve called VRX and a ton of other such stocks in these positions, and done very well in the past.

We’ll be looking to the VRX Weekly $12 and 12.50 Calls* for possible swing trades today.

*We never include mentions of weekly options contracts on a Friday without explicitly warning our readers that trading weekly options at the end of the week is a hugely risky proposition that should not be attempted unless you are an expert trader! 


Ampio Pharmaceuticals, Inc. AMPE

We want to point out a possible momentum play in AMPE. We’ve talked about this stock in the past, and as you can see from the included chart snapshot, it has been mounting a decent rebound effort off of a double bottom over the past few sessions.

We’re going to place AMPE on watch into next week, as a similar move to the one exhibited by the stock earlier this spring would mean considerable gains from this point.


Extended Watchlist:
HOS, MYO, CLSN, TAUG, GAHC, BTSC

Blue Horseshoe Stocks: Updates, Fresh Plays & More

Kraig Biocraft Laboratories, Inc. KBLB

We alerted KBLB in Wednesday morning’s premarket report, and on that day, we would observe a PPS low of .0261. Yesterday, the stock hit a high of .0395, for a respectable two-session upswing of 51%

Following that solid run-up, we saw the stock close at .0375, maintaining a vast majority of its advance. We’ll continue to keep a steady eye on KBLB, and look for it to maintain support above the .03-mark in order to keep us interested.


Potential Bottom-Plays

Rennova Health, Inc. RNVA – We have an interesting story unfolding with RNVA, and a potential rebound opportunity as well. After briefly cracking its 50DMA on Wednesday, the stock took a major gut punch yesterday as it gapped down immensely.

It seems a bit of an overreaction after reading the PR that apparently catalyzed the selloff. The company announced yesterday that it had priced a public offering with the intent of raising upwards of $8.6M in capital, expected to close by Tuesday. They set the purchase price at .45, which is why a massive slide to less than .30 seemed disproportionate.

We’ll be interested to see the activity in this now majorly-oversold stock in sessions to come.


__________

Ampio Pharmaceuticals, Inc. AMPE
– Speaking of stocks that have recently gapped down hard and found new lows, we have AMPE hitting our bottom-play radar.

Similar to the aforementioned play, the selloff occurred as a result of what some might construe as over-reactive. The company released data from a clinical study at the end of last month on its osteoarthritis injection treatment that was poorly-received.  However, while the primary endpoints of the double-blind study were not met, the treatment was markedly effective in improving the patients with the most extreme cases of the condition.

So the study was not a total loss, and the company made clear its intent to submit an FDA application for the treatment for those severely afflicted patients that were helped, and for whom no other non-surgical alternative exists.

That’s why we’ll be keeping an eye on AMPE to continue to regain some of its lost ground, as it has done over the past few sessions.


Extended Watchlist:
MAXD, MFST, PPHM, FES, SPU, KURA, COSI(Bottom watch)

Blue Horseshoe Stocks: Reviewing COTE, DNRG & More

Coates International, Ltd. COTE

After tracking COTE over a monstrous 560% swing (.0025-.0165) on Tuesday, we cautioned readers that a dip-and-rip might be in the cards yesterday, and it’s a good thing that we did.

The follow-up move managed by COTE was smaller by comparison, but still very impressive in and of itself. The daily range on the stock was huge, as it surged from .0068 and once again ran into resistance at .0165. It marked an intraday move of 142% and came on more than six times the monthly average volume.

We’ll continue to reserve a place on our watchlist for COTE as we head into the end of the week; if its activity thus far is any indicator, we may yet see the development another opportunity for healthy daily gains.


Dominovas Energy Corp. DNRG

DNRG exploded off of our extended watchlist yesterday, where we included a tag of it and the interesting PR we found on a routine scan. It appeared others found it interesting as well, because the stock went on an absolute rip from .005 to .0125; a single session swing of 150%

It was fortunate that we were vigilant enough to catch this play for ourselves and our readers, which up until this week, had been trading by appointment only. After the considerable momentum in the stock yesterday, we’ll be tracking its activity for the remainder of the week.


Yesterday’s Successful Options Ideas

We tossed out some options-trading ideas in yesterday’s premarket report, and the profits were certainly there for the taking:

LinkedIn Corp. LNKD – We provided a wide range of LNKD contracts to monitor- Weekly $205.00-212.50′s:

$205′s – Range: 6.00-10.30 – Max Gain: 72%
$207.50′s – Range: 4.20-8.00 – Max Gain: 90%
$210′s – Range: 2.60-6.00 – Max Gain: 131%
$212.50′s – Range: 1.58-4.00 – Max Gain: 153%

The longer-term ideas we included for LNKD also bore fruit immediately:

08/21 $220′s – Range: 9.80-12.00 – Max Gain: 22%
08/21 $225′s – Range: 8.15-9.90 – Max Gain: 21%
08/21 $230′s – Range: 5.10-8.00 – Max Gain: 57%

____

Petroleo Brasiliero SA (Petrobras) PBR -  We tagged the Weekly PBR $8.00-9.00 Calls for observation on PBR, and while the $8′s didn’t see much in the way of open interest, the $8.50′s ran from .38-.63 (+65%) and the $9′s made an even double bagger from .11-.22.


Extended Watchlist:
AVEO, GEVO, EKSO, DARA, NBY, NEON, AMPE

Blue Horseshoe Stocks: Recap of Yesterday’s Huge Session

Our first order of business today will be to go over the wealth of premium gain opportunities contained in yesterday’s premarket report. We had not one, but three of our selections make major moves, not to mention a couple of other modest gainers.

Prima BioMed, Ltd. PBMD

Quickly shooting to the top of our watchlist was PBMD. Its performance was exhilarating to behold as the stock went on an absolute tear from a low of 2.08 on up to 6.48. It marked an epic intraday run which produced total possible gains on the order of 211%

The move occurred on monstrous volume to the tune of nearly 62X the 3-month average, and stemmed largely from some positive results on one of the company’s trial drugs, announced Tuesday. >> READ PR

With the kind of momentum we’ve witnessed building up in just a single session from PBMD, we’re very interested to continue to follow the price action. A significant dip-and-rip scenario could soon present itself.


IsoRay, Inc. ISR

We also tagged ISR in yesterday’s extended watchlist, and it too shot up rapidly with the help of optimistic results from one of its own drug trials. From an early low of 1.86, the stock ran up as high as 3.38, carving out an intraday rip of 82%

This morning, we saw ISR go as high as 4.00 in premarket trading, extending the overnight range on this play to an eyebrow-raising 115%

We’ll certainly be monitoring this stock as we cruise into week’s end. Like PBMD, we’ll be on the lookout for profit-taking to possibly put a dip-and-rip scenario into effect.


Holiday Island Holdings, Inc. HIHI

In our closing thought from yesterday’s report, we called attention to a massive one-third share reduction being enacted by HIHI, and were extremely pleased to have done so. From a low of .0015, the stock broke out to hit .00265; a healthy move totaling 76%

We then saw it pull back into the close, but we’re not finished monitoring the stock by any means. We caught wind of a promotion (in which we are not involved) going out on HIHI this morning, which could provide us with an impeccably-timed boost to extend our profits as we look to take them off the table.


In light of the monumental performances we’ve seen out of news-fueled pharma plays this week, we’ve dug up a few more this morning for us to pin to our watchlists:

Calithera Biosciences, Inc. CALA

Actinium Pharmaceuticals, Inc. ATNM

Ampio Pharmaceuticals, Inc. AMPE


Extended Watchlist:
NSPR, CTP, AVEO

Blue Horseshoe Stocks: DGLY, DRNE, APPG & Extended Watchlist

Digital Ally, Inc. DGLY

Our tag of DGLY prior to Thursday’s session had brought an excellent chance to collect up to 39% in profits last week as DGLY traded in a range from 5.75-8.00 that day.

The stock performed well for us for the second straight day on Friday, registering higher lows and higher highs. We saw DGLY run up from 7.10 to a high of 8.65, a 22% intraday gain. Measuring Friday’s high from the low we observed Thursday, marked an overall two-day increase of 50%

That figure increases dramatically when measured against this morning’s premarket high of 9.74. Anyone fortunate enough to pick up DGLY from the 5.75-mark would be looking at gains in excess of 69% at that level.


Drone Aviation Holding Corp. DRNE

We flagged DRNE in Friday’s Extended Watchlist and were pleased at the move the stock made from its early morning low of .89. It ran into the close and achieved a high of 1.10, an increase of roughly 24% on nearly 10x the average monthly volume.

The stock hadn’t traded that much volume since April, so we really did come upon DRNE at an opportune time.


Apptigo International, Inc. APPG

APPG is a bottom-bouncer that we wanted to mention this morning. On Friday the stock hit, and began to rebound off of its 52-week low of .366, closing at .51, just a penny below its high of day on twice the average monthly volume.

We are seeing a fresh PR out on APPG this morning as well:

MIAMI, FL–(Marketwired – Aug 25, 2014) – Apptigo International, Inc. (OTCBB: APPG) (OTCQB: APPG), a non-conforming, highly creative agency and mobile app developer, today announced that the Company has been invited to present at the National Investment Banking Association’s (“NIBA”) 132nd Investment Conference to be held in New York City on September 15-17, 2014. >> FULL PR


Extended Watchlist:
MGT, MRNA, FOLD, AMPE, XGTI, TOPS,
RGDO
(Big gap down radar for possible bounce)